Oxidative stress in subsynovial connective tissue of idiopathic carpal tunnel syndrome

Journal of Orthopaedic Research

Volumn 28, Issue 11, 2010, Pages 1463-1468

  Kim, Jae Kwang ^a   Koh, Young Do ^a   Kim, Jeong Suk ^a   Hann, Hoo Jae ^a   Kim, Mi Jin ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Idiopathic carpal tunnel syndrome; Oxidative stress; Subsynovial connective tissue

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CONNECTIVE TISSUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; SYNOVIUM;

ADULT; AGED; CARPAL TUNNEL SYNDROME; CONNECTIVE TISSUE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SYNOVIAL MEMBRANE;

EID: 77957965528     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21163     Document Type: Article

References (35)

1. Bland JD. 2005. Carpal tunnel syndrome. Curr Opin Neurol 18:581-585.
2. Hirata H, Tsujii M, Yoshida T, et al. 2005. MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. J Pathol 205:443-450.
3. Nakamichi K, Tachibana S. 1998. Histology of the transverse carpal ligament and flexor tenosynovium in idiopathic carpal tunnel syndrome. J Hand Surg Am 23:1015-1024.
4. Tanzer RC. 1959. The carpal-tunnel syndrome; a clinical and anatomical study. J Bone Joint Surg Am 41:626-634.
5. Brahme SK, Hodler J, Braun RM, et al. 1997. Dynamic MR imaging of carpal tunnel syndrome. Skeletal Radiol 26:482-487.
6. Horch RE, Allmann KH, Laubenberger J, et al. 1997. Median nerve compression can be detected by magnetic resonance imaging of the carpal tunnel. Neurosurgery 41:76-83.
7. Hirata H, Nagakura T, Tsujii M, et al. 2004. The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol 204:605-612.
8. Ettema AM, Amadio PC, Zhao C, et al. 2004. A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 86:1458-1466.
9. Freeland AE, Tucci MA, Barbieri RA, et al. 2002. Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 22:378-385.
10. Levine DW, Simmons BP, Koris MJ, et al. 1993. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am 75:1585-1592.
11. Lee BL, Kim WH, Jung J, et al. 2008. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 29:44-51.
12. Jinrok O, Zhao C, Amadio PC, et al. 2004.Vascular pathologic changes in the flexor tenosynovium (subsynovial connective tissue) in idiopathic carpal tunnel syndrome. J Orthop Res 22:1310-1315.
13. Luque Contreras D, Vargas Robles H, Romo E, et al. 2006. The role of nitric oxide in the post-ischemic revascularization process. Pharmacol Ther 112:553-563.
14. Zhang R,Wang L, Zhang L, et al. 2003. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 92:308-313.
15. Boo YC, Jo H. 2003. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol 285:499-508.
16. Silvestre JS, Tamarat R, Senbonmatsu T, et al. 2002. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 90:1072-1079.
17. Schreck R, Albermann K, Baeuerle PA. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17:221-237.
18. Bowie A, O'Neill LA. 2000. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23.
19. Schreck R, Meier B, Mannel DN, et al. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194.
20. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidantresponsive factor. EMBO J 12:2005-2015.
21. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258.
22. Schmidt KN, Amstad P, Cerutti P, et al. 1995. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol 2:13-22.
23. Bonizzi G, Piette J, Schoonbroodt S, et al. 1999. Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol 19:1950-1960.
24. Manna SK, Zhang HJ, Yan T, et al. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273:13245-13254.
25. Liu RM, Gaston Pravia KA. 2010. Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic Biol Med 48:1-15.
26. Cucoranu I, Clempus R, Dikalova A, et al. 2005. NAD(P)H oxidase 4 mediates transforming growth factor-beta1. induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97:900-907.
27. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270:30334-30338.
28. 2 release from bovine pulmonary artery endothelial cells induced by TGF-beta 1. Am J Physiol 265:622-626.
29. Kayanoki Y, Fujii J, Suzuki K, et al. 1994. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J Biol Chem 269:15488-15492.
30. Jobling MF, Mott JD, Finnegan MT, et al. 2006. Isoformspecific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res 166:839-848.
31. Leonarduzzi G, Scavazza A, Biasi F, et al. 1997. The lipid peroxidation end product 4-hydroxy-2,3-nonenal upregulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11:851-857.
32. Chan L, Turner JA, Comstock BA, et al. 2007. The relationship between electrodiagnostic findings and patient symptoms and function in carpal tunnel syndrome. Arch Phys Med Rehabil 88:19-24.
33. Padua L, Padua R, Aprile I, et al. 2002. Carpal tunnel syndrome: relationship between clinical and patientoriented assessment. Clin Orthop Relat Res 395:128-134.
34. Bessette L, Keller RB, Liang MH, et al. 1997. Patients' preferences and their relationship with satisfaction following carpal tunnel release. J Hand Surg Am 22:613-620.
35. Tsujii M, Hirata H, Morita A, et al. 2009. Palmar bowing of the flexor retinaculum on wrist MRI correlates with subjective reports of pain in carpal tunnel syndrome. JMagn Reson Imaging 29:1102-1105.